HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

victomycin

Subscribe to New Research on victomycin

Share|Follow on Twitter

antibiotic belonging to phleomycin-bleomycin group

Also Known As:

XK 49-1-B-2

Networked: 1 relevant articles (0 outcomes, 0 trials/studies) for this Bio-Agent, Comments

Bio-Agent Context: Research Results

Carbohydrates: 2860
- Glycoconjugates: 578
  - Glycopeptides: 489
    - Bleomycin: 4984
      - victomycin: 1
Amino Acids, Peptides, and Proteins
- Peptides: 16242
  - Glycopeptides: 489
    - Bleomycin: 4984
      - victomycin: 1

Related Diseases

1.	Sarcoma 180 05/01/1975 - "A new antibiotic, victomycin, is active against a variety of Gram-positive and Gram-negative bacteria, and also has in vivo activity against solid Sarcoma 180 and Ehrlich ascites carcinoma. " Order ALL the reference details at left...
2.	Carcinoma (Carcinomatosis) 05/01/1975 - "A new antibiotic, victomycin, is active against a variety of Gram-positive and Gram-negative bacteria, and also has in vivo activity against solid Sarcoma 180 and Ehrlich ascites carcinoma. " Order ALL the reference details at left...
3.	Ascites 05/01/1975 - "A new antibiotic, victomycin, is active against a variety of Gram-positive and Gram-negative bacteria, and also has in vivo activity against solid Sarcoma 180 and Ehrlich ascites carcinoma. " Order ALL the reference details at left...

blog comments powered by Disqus

TREATMENT OPTIONS
for Sarcoma 180,
Ranking and Evidence

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 19 Outcomes
Top 200 Key Drugs and Biologics
Top 25 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$8.50 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$45.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>